Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders
NEW YORK, June 1, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities law violations at Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN).
Request more information now by clicking here: www.faruqilaw.com/SUPN. There is no cost or obligation to you.
Take Action
If you currently own Supernus stock and would like to discuss your legal rights, please visit www.faruqilaw.com/SUPN. You can also contact us either by calling Nina M. Varindani toll free at (212) 983-9330 or by sending an e-mail to [email protected], or by sending an email to Michael Van Gorder at [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Supernus's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CONTACT:
Nina M. Varindani
Michael Van Gorder
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
[email protected]
[email protected]
Telephone: (212) 983-9330
SOURCE Faruqi & Faruqi, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article